Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07649057 · ClinicalTrials.gov registry record
A Study of a Urine Test to Detect Colorectal Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 210
- Enrollment target
NCT07649057: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07649057 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07649057 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 210 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Interventions
- DIAGNOSTIC_TEST 3-metabolite biosensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2026-06-11 |
| Est. Completion | 2028-06-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07649057
The ClinicalTrials.gov registry entry for NCT07649057 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3-metabolite biosensor is the first listed.
NCT07649057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07649057 about?
NCT07649057 is a clinical study titled "A Study of a Urine Test to Detect Colorectal Cancer". The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
What is the current status of trial NCT07649057?
This trial is currently recruiting. The enrollment target is 210 participants. The study started on 2026-06-11. Estimated completion is 2028-06-11.
What interventions are being tested in trial NCT07649057?
The interventions under investigation include: 3-metabolite biosensor (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07649057?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.